A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants

• Главные авторы: Shugang Qin (Автор), Hai Huang (Автор), Wen Xiao (Автор), Kepan Chen (Автор), Xi He (Автор), Xiaoshan Tang (Автор), Zhiying Huang (Автор), Yupei Zhang (Автор), Xing Duan (Автор), Na Fan (Автор), Qian Zheng (Автор), Min Wu (Автор), Guangwen Lu (Автор), Yuquan Wei (Автор), Xiawei Wei (Автор), Xiangrong Song (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2023-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

There are currently approximately 4000 mutations in the SARS-CoV-2 S protein gene and emerging SARS-CoV-2 variants continue to spread rapidly worldwide. Universal vaccines with high efficacy and safety urgently need to be developed to prevent SARS-CoV-2 variants pandemic. Here, we described a novel...